A class-action lawsuit over the strategies that Merck used to market its painkiller Vioxx in Australia is earning the American drug maker some bad publicity.
Trial Puts Spotlight on MerckCourtesy NYT > Business Wed, 05/13/2009 - 20:11
A class-action lawsuit over the strategies that Merck used to market its painkiller Vioxx in Australia is earning the American drug maker some bad publicity. Related itemsUS high court to decide on allowing Vioxx suits
Novartis to pay $99 M to settle overtime lawsuit
Women charging sex bias have until Oct. 28 to sue...
Samsung SCX-4200 3-in-1 True Multifunction Printer
Canon 13 x 19 Inch Semi Gloss Photo Paper Plus, 20...
|
Popular by tags WeekMonth |
Post new comment